AU6408196A - Genetic therapy employing the hhv-6a derived ts gene or polypeptide - Google Patents

Genetic therapy employing the hhv-6a derived ts gene or polypeptide

Info

Publication number
AU6408196A
AU6408196A AU64081/96A AU6408196A AU6408196A AU 6408196 A AU6408196 A AU 6408196A AU 64081/96 A AU64081/96 A AU 64081/96A AU 6408196 A AU6408196 A AU 6408196A AU 6408196 A AU6408196 A AU 6408196A
Authority
AU
Australia
Prior art keywords
hhv
polypeptide
gene
derived
genetic therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64081/96A
Inventor
John C. Araujo
Jay Doniger
Leonard J. Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of AU6408196A publication Critical patent/AU6408196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU64081/96A 1995-07-10 1996-07-09 Genetic therapy employing the hhv-6a derived ts gene or polypeptide Abandoned AU6408196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US101095P 1995-07-10 1995-07-10
US001010 1995-07-10
PCT/US1996/011222 WO1997002841A1 (en) 1995-07-10 1996-07-09 Genetic therapy employing the hhv-6a derived ts gene or polypeptide

Publications (1)

Publication Number Publication Date
AU6408196A true AU6408196A (en) 1997-02-10

Family

ID=21693952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64081/96A Abandoned AU6408196A (en) 1995-07-10 1996-07-09 Genetic therapy employing the hhv-6a derived ts gene or polypeptide

Country Status (2)

Country Link
AU (1) AU6408196A (en)
WO (1) WO1997002841A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6874089B2 (en) 2002-02-25 2005-03-29 Network Resonance, Inc. System, method and computer program product for guaranteeing electronic transactions
US20110142918A1 (en) * 2008-06-12 2011-06-16 Phoebus S.R.L. Anti-angiogenic compositions and therapeutic applications thereof

Also Published As

Publication number Publication date
WO1997002841A1 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
AU8116494A (en) Gene signature
AU4787697A (en) Therapeutic gene
AU3739697A (en) Gene delivery system
AU699706C (en) Improved vectors for gene therapy
AU6255096A (en) Pegylated modified proteins
AU1797799A (en) Impedance-heated furnace
AU5324196A (en) Gene transfer into the kidney
AU2036897A (en) Cftr gene regulator
AU1308699A (en) Heater control
AU1365099A (en) Infusion system with improved control valve
EP0739983A3 (en) Gene encoding lacto-n-biosidase
AU5590394A (en) Transglutaminase gene
AU5498198A (en) Beta-ketoacyl-acp-synthetase ii enzyme and gene encoding the same
AU1991799A (en) Molecules associated with the human suppressor of fused gene
AU6254799A (en) Anti-ige gene therapy
AU6679094A (en) Genetic stabilizing elements
AU7457596A (en) The aiolos gene
AU6408196A (en) Genetic therapy employing the hhv-6a derived ts gene or polypeptide
AU4941096A (en) Self-deleting vectors for gene therapy
AU9380898A (en) Mammalian circadian rhythm-like gene
AU4891697A (en) Individual mirror control system
AUPP617598A0 (en) Genetic sequence and uses therefor
AU7215596A (en) Gene therapy with modified p65 proteins
AU6007098A (en) Bioreactor control
AU9175398A (en) Novel control system